Rose Fernandes is currently a Compound Management and Synthesis Intern at AstraZeneca, having started in July 2025. Before this role, Rose participated in the Broadening Horizons in the Chemical Sciences program with the Royal Society of Chemistry from June 2024 to July 2025, which included networking events and site visits to learn about workplace culture. Rose is pursuing an MSci in Chemistry with Computing at the University of Bristol, expected to graduate in 2027, and completed secondary education at St Bernard's Catholic Grammar School from 2016 to 2023.
This person is not in the org chart
This person is not in any teams
This person is not in any offices